Related Experiment Video
Updated: Mar 13, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
Anastasia Asimakopoulou1, Sabine Weiskirchen1, Ralf Weiskirchen1
1Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry, RWTH University Hospital Aachen Aachen, Germany.
Lipocalin 2 (LCN2) is a protein involved in transporting molecules and shows protective roles in liver injury. Its altered expression is linked to various diseases, making it a potential biomarker for liver conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Lipocalin 2 (LCN2) is a secreted protein known for transporting lipophilic molecules.
- Altered LCN2 expression is implicated in diverse pathological conditions, including liver injury, steatosis, and cancer.
- Recent research highlights LCN2's significance in physiological states and cellular stress responses.
Approach:
- This review synthesizes experimental and clinical findings on LCN2.
- Focuses on the role of LCN2 in the pathogenesis of liver disease.
- Examines LCN2's involvement in both acute and chronic liver injury models.
Key Points:
- LCN2 exhibits a protective role in liver injury models, with highly elevated expression.
- LCN2 expression is associated with conditions such as hepatic steatosis, hepatic damage, and inflammation.
- LCN2 is emerging as a potential biomarker for various pathological conditions, including rheumatic diseases and cancers.
Conclusions:
- LCN2 plays a critical role in the pathogenesis of liver disease.
- Its expression levels can serve as a valuable biomarker for diagnosing and monitoring liver conditions.
- Further research into LCN2's mechanisms may offer therapeutic insights.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Cell Specific Gene Expression
Chronic Kidney Disease II: Clinical Manifestations